Oseltamivir Phosphate for Oral Suspension 6mg/ml recall: Impurity Out of Spec
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Why was Oseltamivir Phosphate for Oral Suspension 6mg/ml recalled?
Failed Impurities/Degradation Specifications: Out-of-specification test results.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024
- Product
- Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
- Recalling firm
- Amneal Pharmaceuticals of New York, LLC
- Quantity
- 46,037 Bottles
- Distribution
- Nationwide in the USA
- Recall date
- February 28, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)